Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch
What You Should Know: – Biolinq, a provider of precision wearable biosensors for metabolic health secures $58M led by Alpha Wave Ventures. The round will include participation from Niterra’s corporate venture capital fund jointly…
Continue Reading